Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CRISPR-Drug Combinatorial Screening Identifies Effective Combination Treatments for MTAP-Deleted Cancer.

Cancer research·2025

Same author

The three YTHDF paralogs and VIRMA are strong cross-histotype tumor driver candidates among m<sup>6</sup>A core genes.

NAR cancer·2024

Same author

Early Clinical Success of MTA-Cooperative PRMT5 Inhibitors for the Treatment of CDKN2A/MTAP-Deleted Cancers.

Cancer discovery·2023

Same author

Alpha-1 Adrenergic Antagonists Sensitize Neuroblastoma to Therapeutic Differentiation.

Cancer research·2023

Same author

Translational enhancement by base editing of the Kozak sequence rescues haploinsufficiency.

Nucleic acids research·2022

Same author

QUADRatlas: the RNA G-quadruplex and RG4-binding proteins database.

Nucleic acids research·2022

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

ARF beyond p53: Shaping the Pancreatic Tumor Microenvironment.

Eliana Destefanis¹, Kathleen M Mulvaney^1,2,3

¹FBRI Cancer Research Center, Fralin Biomedical Research Institute, Virginia Tech, Washington, District of Columbia.

Cancer Research

|July 2, 2026

Summary

The tumor suppressor p14ARF regulates the pancreatic cancer microenvironment independently of p53. Loss of ARF is linked to stromal remodeling, suggesting ARF as a therapeutic target.

More Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Jul 3, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture

Published on: September 27, 2024

Area of Science:

Oncology
Cancer Biology
Tumor Microenvironment

Background:

p14ARF is a known tumor suppressor that stabilizes and activates p53.
Its role in pancreatic ductal adenocarcinoma (PDAC) development is not fully understood.

Purpose of the Study:

To investigate the function of p14ARF in PDAC development.
To explore its role in regulating the tumor microenvironment independently of p53.

Main Methods:

Analysis of ARF expression in PDAC.
Assessment of tumor microenvironment characteristics associated with ARF loss.

Main Results:

ARF loss is associated with significant stromal remodeling in PDAC.
This remodeling includes increased extracellular matrix deposition and fibroblast infiltration.
ARF's function in regulating the tumor microenvironment is p53-independent.

Conclusions:

p14ARF plays a role in regulating the PDAC tumor microenvironment.
ARF loss contributes to a pro-tumorigenic microenvironment.
ARF is a potential upstream regulator and therapeutic target for PDAC.